Johns Hopkins ABX Guide →Brand Names

Sofosbuvir + Ledipasvir

Janessa M. Smith, PharmD, BCPS
Sofosbuvir + Ledipasvir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of chronic hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection.
    • Indicated for treatment of HCV infection in treatment-experienced patients without cirrhosis and with compensated cirrhosis (Child-Pugh A) or decompensated cirrhosis (Child-Pugh B or C)
    • Treatment-naïve patients with compensated cirrhosis (Child-Pugh A) or decompensated cirrhosis (Child-Pugh B or C), and liver transplant recipients.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 31, 2016

Citation

TY - ELEC T1 - Sofosbuvir + Ledipasvir ID - 540671 A1 - Smith,Janessa,PharmD, BCPS Y1 - 2016/07/31/ PB - Johns Hopkins ABX Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_ABX_Guide/540671/all/Sofosbuvir_+_Ledipasvir ER -